Evidence map›Paper›PMID 18778710›Full record

ArticleGastroenterology2008

Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene.

Brian D Juran, Elizabeth J Atkinson, Erik M Schlicht, Brooke L Fridley, Konstantinos N Lazaridis

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01161953 (Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01161953 completednot on this map

Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis (PBC).

TypeobservationalSponsorMayo ClinicRan2002 to 2025Enrolled1,500ConditionsPrimary Biliary CirrhosisArmsGenetic Analysis
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Impact of microbes on autoimmune diseases.Archivum immunologiae et therapiae experimentalis · 2013
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Brian D JuranCenter for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
Elizabeth J Atkinson
Erik M Schlicht
Brooke L Fridley
Konstantinos N Lazaridis
Mayo Clinic · US

Funding

Genomics of Primary Biliary CirrhosisR01DK080670 · NIDDK · MAYO CLINIC ROCHESTER · PI LAZARIDIS, KONSTANTINOS N · 2008 to 2015
$2.9M
Genetic Epidemiology of Primary Biliary CirrhosisK23DK068290 · NIDDK · MAYO CLINIC ROCHESTER · PI LAZARIDIS, KONSTANTINOS N · 2004 to 2008
$627k
Dissecting the Aggregation of AMA in Families of PBC PatientsR03DK078527 · NIDDK · MAYO CLINIC ROCHESTER · PI LAZARIDIS, KONSTANTINOS N · 2007 to 2008
$150k
NIDDK NIH HHS K23 DK068290NIDDK NIH HHS K23 DK68290NIDDK NIH HHS R01 DK080670NIDDK NIH HHS R01 DK80670NIDDK NIH HHS R03 DK078527NIDDK NIH HHS R03 DK78527
6 · The paper itself

Abstract

BACKGROUND &

aimsGenetic variation is invoked as a strong component underlying primary biliary cirrhosis (PBC) and other autoimmune disorders. Data suggest that some of this genetic risk is shared, affecting function of the immune mechanisms controlling self-tolerance. Cytotoxic T-lymphocyte antigen 4 (CTLA4) encodes a coinhibitory immunoreceptor that is a key regulator of self-tolerance with established genetic associations to multiple autoimmune diseases but conflicting evidence of involvement with PBC. We aimed to perform a more comprehensive assessment of CTLA4 genetic variation in PBC using a haplotype-tagging based approach.

methodsSingle nucleotide polymorphisms (SNPs) were genotyped in 402 PBC patients and 279 controls and evaluated for association with PBC and with antimitochondrial antibody (AMA) status and prior orthotopic liver transplantation (OLT) among the PBC patients, both individually and as inferred haplotypes, using logistic regression.

resultsAll SNPs were in Hardy-Weinberg equilibrium. We identified a novel and relatively strong association between PBC and rs231725, a SNP in the 3' flanking region of CTLA4 located outside of the area previously investigated in PBC. This SNP tags a common CTLA4 haplotype that contains a number of functionally implicated autoimmune CTLA4 SNPs, which was also found to be associated with PBC and to a lesser extent AMA status and prior OLT.

conclusionsOur findings suggest that CTLA4 has an impact on the risk of PBC and possibly plays a role in influencing AMA development as well as progression to OLT among PBC patients. Replication in a suitable, independent PBC cohort is needed.

Indexed as

Polymorphism, Single Nucleotide3' Flanking RegionAdultAgedAged, 80 and overAntigens, CDCTLA-4 AntigenFemaleGenetic Predisposition to DiseaseGenetic VariationHaplotypesHumansLiver Cirrhosis, BiliaryLiver TransplantationLogistic ModelsMaleAntigens, CDCTLA-4 AntigenCTLA4 protein, human

Identifiers

PMID18778710
PMCPMC2613835
OpenAlexW2071616199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.